Neoplasms
50 researchers across 6 institutions
Research in neoplasms investigates the fundamental biological processes underlying tumor formation, growth, and spread. Investigations explore the molecular and cellular mechanisms that drive cancer development, including genetic mutations, epigenetic alterations, and signaling pathway dysregulation. Studies also address the tumor microenvironment, immune system interactions with cancer, and the processes of metastasis. Methodologies include advanced genomic and proteomic analyses, cell culture models, animal studies, and the examination of clinical data to understand disease progression and identify therapeutic targets.
This research holds significant relevance for Arkansas. The state faces considerable public health challenges related to cancer incidence and mortality, making advancements in understanding and treating neoplasms a priority. Research efforts contribute to improving health outcomes for Arkansans and can inform public health policy and clinical practice. Furthermore, the development of novel diagnostic and therapeutic strategies has the potential to foster economic growth within the state's growing biotechnology and healthcare sectors.
This area of study draws upon expertise in molecular biology, genetics, immunology, pharmacology, and pathology. It involves collaborations with researchers in medical imaging, health disparities, and systematic reviews, reflecting a broad interdisciplinary approach across multiple Arkansas higher education institutions.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| David M. Parham | UAMS | 81 | 21,060 | High Impact | |
| Fred Prior | UAMS | 36 | 13,709 | Grant PI High Impact | |
| John D. Pemberton | UAMS | 19 | 1,720 | ||
| Andrew Johns | University of Central Arkansas | 12 | 525 | ||
| Roni M. Cox | UAMS | 11 | 538 | ||
| Cem Cengız | UAMS | 10 | 361 | ||
| Jennifer L. Harman | UAMS | 9 | 288 | ||
| Skyler Jenkins | UAMS | 9 | 360 | ||
| Richard E. Gardner | UAMS | 9 | 379 | ||
| Avinash Thombre | UA Little Rock | 8 | 258 | ||
| Ravi P. Cholia | UAMS | 7 | 324 | ||
| Aisulu Usubalieva | UAMS | 6 | 275 | ||
| Edvaldo Galhardo | UAMS | 5 | 157 | ||
| Bahaa Mustafa | UAMS | 4 | 95 | ||
| Mamatha Gaddam | UAMS | 4 | 60 | ||
| Emory Gregory | University of Arkansas | 4 | 264 | ||
| Vivek Yadala | UAMS | 4 | 100 | ||
| Aditi Chaurasia | UAMS | 4 | 32 | ||
| Sondos Al Khatib | UAMS | 4 | 28 | ||
| Khandoker Usran Ferdous | UAMS | 4 | 58 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Neoplasms in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 The University of Texas MD Anderson Cancer Center 2,791
- 2 Mayo Clinic in Arizona 1,712
- 3 Mayo Clinic 1,347
- 4 Harvard University 1,172
- 5 Cleveland Clinic 1,083
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Neoplasms.